Not applicableLooking for participantsNCT05003310What this trial is testingConsideRAte Study - Splenic Stimulation for RAWho this might be right forRheumatoid Arthritis Galvani Bioelectronics 28
Large-scale testing (Phase 3)Study completedNCT01173120What this trial is testingMethotrexate - Inadequate Response Device Sub-StudyWho this might be right forRheumatoid Arthritis (RA) Bristol-Myers Squibb 62
Post-approval studies (Phase 4)Study completedNCT01224418What this trial is testingEvaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateWho this might be right forRheumatoid Arthritis Astellas Pharma Inc 50
Early research (Phase 1)WithdrawnNCT00717808What this trial is testingEffects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Imperial College London
Large-scale testing (Phase 3)Study completedNCT01197755What this trial is testingEvaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistWho this might be right forRheumatoid Arthritis AstraZeneca 323
Not applicableStudy completedNCT06718985What this trial is testingImpact of Bone Mineral Density on Fracture Risk Assessment in RAWho this might be right forRheumatoid Arthritis Istanbul Physical Medicine Rehabilitation Training and Research Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT01242514What this trial is testingEvaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis AstraZeneca 1,917
Testing effectiveness (Phase 2)Study completedNCT00074438What this trial is testingStudy to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Genentech, Inc. 465
Testing effectiveness (Phase 2)UnknownNCT03435601What this trial is testingTarget the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)Who this might be right forRheumatoid Arthritis Josef Smolen, Univ. Prof. Dr. 24
Post-approval studies (Phase 4)Study completedNCT00280644What this trial is testingLeflunomide in Rheumatoid ArthritisWho this might be right forArthritis, Rheumatoid Sanofi 60
Not applicableStudy completedNCT01197144What this trial is testingPain Modulation in Rheumatoid Arthritis (RA) - Influence of AdalimumabWho this might be right forArthritis, RheumatoidPainFatigue Karolinska Institutet 70
Testing effectiveness (Phase 2)Study completedNCT00369928What this trial is testingEvaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving MethotrexateWho this might be right forRheumatoid Arthritis Procter and Gamble 254
Post-approval studies (Phase 4)Looking for participantsNCT07087912What this trial is testingSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesWho this might be right forRheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more University of Sao Paulo General Hospital 477
Early research (Phase 1)Looking for participantsNCT05197530What this trial is testingImaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis University of Rochester 40
Not applicableStudy completedNCT00612885What this trial is testingSafety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational StudyWho this might be right forOsteoarthritisArthritis, Rheumatoid Boehringer Ingelheim 425
Early research (Phase 1)Study completedNCT02819726What this trial is testingPK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Archigen Biotech Limited 294
Not applicableStudy completedNCT04089514What this trial is testingA Real-world Study of Imraldi® UseWho this might be right forArthritis, Rheumatoid (RA)Axial Spondyloarthritis (axSpA)Arthritis, Psoriatic (PsA)+2 more Biogen 1,000
Early research (Phase 1)Study completedNCT02247375What this trial is testingPharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)Who this might be right forArthritis, Rheumatoid Boehringer Ingelheim 26
Not applicableStudy completedNCT01774877What this trial is testingA Clinical Study of Xin'an Medicine in the Treatment of Bi SyndromeWho this might be right forRheumatoid Arthritis The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine 304
Post-approval studies (Phase 4)Looking for participantsNCT06906549What this trial is testingEvaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA)Rituximab (RTx) University Hospital, Strasbourg, France 260